PI

Live / Applied — Suspended — suspension check completed, case still suspended (as of 11 Feb 2025)

What this means for you

Not registered yet, but its 25 May 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
90732722
Mark type
Stylized text
Filed
25 May 2021
Attorney of record
Richard S. Finkelstein

Goods and services

  • Class 009 — Scientific and electric apparatus: Downloadable software for analysis of medical images and data; Downloadable software for providing medical diagnostic services; Downloadable software in the field of cancer for cancer screening, cancer detection and cancer diagnosis; Downloadable software for screening cancer; Downloadable software for detecting cancer; Downloadable software for diagnosing cancer; Downloadable software for screening, detecting and diagnosing prostate cancer; Downloadable software for the analysis of medical data; Downloadable data analysis software for screening, detecting and diagnosing cancer; Downloadable data analysis software for screening, detecting and diagnosing prostate cancer; Downloadable software for processing medical data; Downloadable data processing software for screening, detecting and diagnosing cancer; Downloadable data processing software for screening, detecting and diagnosing prostate cancer; Downloadable machine learning software for analysis of medical images and data; Downloadable machine learning software for screening, detecting and diagnosing cancer; Downloadable machine learning software for screening, detecting and diagnosing prostate cancer; Downloadable artificial intelligence software for analysis of medical images and data; Downloadable artificial intelligence software for screening, detecting and diagnosing cancer; Downloadable artificial intelligence software for screening, detecting and diagnosing prostate cancer; Downloadable software for MRI machines to detect cancer; Downloadable software for operating medical apparatus in the field of cancer; Downloadable software for medical imaging apparatus to detect cancer; Downloadable publications, namely, magazines, pamphlets, journals, in the field of medicine; Downloadable publications, namely, magazines, pamphlets, journals, in the field of cancer, cancer research, cancer screening, cancer diagnosis, cancer treatment, MRI, MRI machines and medical imaging
  • Class 042 — Scientific and technological services: Software as a service (SaaS) featuring software for analysis of medical images and data; Platform as a service (PaaS) featuring software for analysis of medical images and data; Design and development of software; Software as a service (SaaS) featuring software in the field of cancer for cancer screening, cancer detection and cancer diagnosis; Software as a service (SaaS) featuring software for screening, detecting and diagnosing cancer; Software as a service (SaaS) featuring software for screening, detecting and diagnosing prostate cancer; Software as a service (SaaS) featuring software for the analysis of medical data; Software as a service (SaaS) in the nature of data analysis software for screening, detecting and diagnosing cancer; Software as a service (SaaS) in the nature of data analysis software for screening, detecting and diagnosing prostate cancer; Software as a service (SaaS) featuring software for processing medical data; Software as a service (SaaS) in the nature of data processing software for screening, detecting and diagnosing cancer; Software as a service (SaaS) in the nature of data processing software for screening, detecting and diagnosing prostate cancer; Software as a service (SaaS) in the nature of machine learning software for analysis of medical images and data; Software as a service (SaaS) in the nature of machine learning software for screening, detecting and diagnosing cancer; Software as a service (SaaS) in the nature of machine learning software for screening, detecting and diagnosing prostate cancer; Software as a service (SaaS) in the nature of artificial intelligence software for analysis of medical images and data; Software as a service (SaaS) in the nature of artificial intelligence software for screening, detecting and diagnosing cancer; Software as a service (SaaS) in the nature of artificial intelligence software for screening, detecting and diagnosing prostate cancer; Software as a service (SaaS) featuring software for MRI machines to detect cancer; Software as a service (SaaS) featuring software for medical imaging apparatus to detect cancer; Platform as a service (PaaS) featuring software in the field of cancer for cancer screening, cancer detection and cancer diagnosis; Platform as a service (PaaS) featuring software for screening, detecting and diagnosing cancer; Platform as a service (PaaS) featuring software for screening, detecting and diagnosing prostate cancer; Platform as a service (PaaS) featuring software for the analysis of medical data; Platform as a service (PaaS) in the nature of data analysis software platform for screening, detecting and diagnosing cancer; Platform as a service (PaaS) in the nature of data analysis software platform for screening, detecting and diagnosing prostate cancer; Platform as a service (PaaS) featuring software for the processing of medical data; Platform as a service (PaaS) in the nature of data processing software platform for screening, detecting and diagnosing cancer; Platform as a service (PaaS) in the nature of data processing software platform for screening, detecting and diagnosing prostate cancer; Platform as a service (PaaS) in the nature of machine learning platform for analysis of medical images and data; Platform as a service (PaaS) in the nature of machine learning software platform for screening, detecting and diagnosing cancer; Platform as a service (PaaS) in the nature of machine learning software platform for screening, detecting and diagnosing prostate cancer; Platform as a service (PaaS) in the nature of artificial intelligence software platform for analysis of medical images and data; Platform as a service (PaaS) in the nature of artificial intelligence software platform for screening, detecting and diagnosing cancer; Platform as a service (PaaS) in the nature of artificial intelligence software platform for screening, detecting and diagnosing prostate cancer; Platform as a service (PaaS) featuring software platforms for MRI machines to detect cancer; Platform as a service (PaaS) featuring software platforms for medical imaging apparatus to detect cancer; Design and development of software in the field of cancer, cancer screening, cancer detection and cancer diagnosis; Design and development of software for screening, detecting and diagnosing cancer; Design and development of software for screening, detecting and diagnosing prostate cancer; Design and development of data analysis software; Design and development of data analysis software for screening, detecting and diagnosing cancer; Design and development of data analysis software for screening, detecting and diagnosing prostate cancer; Design and development of data processing software; Design and development of data processing software for screening, detecting and diagnosing cancer; Design and development of data processing software for screening, detecting and diagnosing prostate cancer; Design and development of machine learning software; Design and development of machine learning software for screening, detecting and diagnosing cancer; Design and development of machine learning software for screening, detecting and diagnosing prostate cancer; Design and development of artificial intelligence software; Design and development of artificial intelligence software for screening, detecting and diagnosing cancer; Design and development of artificial intelligence software for screening, detecting and diagnosing prostate cancer; Design and development of software for MRI machines; Design and development of software for medical imaging apparatus; Scientific research services; Scientific research services in the field of cancer, cancer screening, cancer detection and cancer diagnosis; Scientific research services in the field of artificial intelligence and machine learning; Testing of computer software; Information and advisory services relating to the aforementioned
  • Class 044 — Medical, beauty and agricultural services: Provision of medical information in the field of prostate cancer; Provision of medical information in the field of cancer, cancer screening, cancer detection and cancer diagnosis; Medical services related to the treatment of cancer; Healthcare services related to the treatment of cancer; Medical analysis services related to the treatment of cancer; Medical analysis services for the diagnosis of cancer; Medical analysis services for the diagnosis of prostate cancer; Medical diagnostic testing, monitoring and reporting services; Medical diagnostic services for cancer; Medical diagnostic services for prostate cancer; Medical consulting services related to the treatment of cancer; Medical consulting services in the field of cancer, cancer screening, cancer detection and cancer diagnosis; Collation being analysis of information in the healthcare sector related to the treatment of cancer; Information and advisory services relating to the aforementioned

Owner

Prosecution history

  • 12 Aug 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
  • 11 Feb 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
  • 20 Dec 2023 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
  • 10 Apr 2023 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
  • 13 Feb 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 13 Feb 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 13 Feb 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 19 Sept 2022 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
  • 19 Sept 2022 — LETTER OF SUSPENSION E-MAILED
  • 19 Sept 2022 — SUSPENSION LETTER WRITTEN
  • 25 Aug 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 25 Aug 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 24 Aug 2022 — ASSIGNED TO LIE
  • 15 Aug 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 15 Feb 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED

View this trademark record on Marksy